Suchergebnisse - "Janetka, James W"

PubPharm (10)

1

Optimizing Pyrazolopyrimidine Inhibitors of Calcium Dependent Protein Kinase 1 for Treatment of Acute and Chronic Toxoplasmosis

enthalten in: Journal of medicinal chemistry | 2020

von Janetka, J. | Hopper, A. | Yang, Z. | +4

2

Adventures in Scaffold Morphing : Discovery of Fused Ring Heterocyclic Checkpoint Kinase 1 (CHK1) Inhibitors

enthalten in: Journal of medicinal chemistry | 2018

von Yang, B. | Vasbinder, M. | Hird, A. | +14

3

Inhibition of Calcium Dependent Protein Kinase 1 (CDPK1) by Pyrazolopyrimidine Analogs Decreases Establishment and Reoccurrence of Central Nervous System Disease by Toxoplasma gondii

enthalten in: Journal of medicinal chemistry | 2017

von Rutaganira, F. | Barks, J. | Dhason, M. | +11

4

Discovery of novel hedgehog antagonists from cell-based screening : Isosteric modification of p38 bisamides as potent inhibitors of SMO

enthalten in: Bioorganic & medicinal chemistry letters | 2012

von Yang, B. | Hird, A. | Russell, D. | +8

5

Death by releasing the breaks : CHK1 inhibitors as cancer therapeutics

enthalten in: Trends in molecular medicine | 2011

von Ma, C. | Janetka, J. | Piwnica-Worms, H.

6

Structure-guided design of potent and selective pyrimidylpyrrole inhibitors of extracellular signal-regulated kinase (ERK) using conformational control

enthalten in: Journal of medicinal chemistry | 2009

von Aronov, A. | Tang, Q. | Martinez-Botella, G. | +18

7

Checkpoint kinase inhibitors : a review of the patent literature

enthalten in: Expert opinion on therapeutic patents | 2009

von Janetka, J. | Ashwell, S.

8

AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies

enthalten in: Molecular cancer therapeutics | 2008

von Zabludoff, S. | Deng, C. | Grondine, M. | +17

9

Keeping checkpoint kinases in line : new selective inhibitors in clinical trials

enthalten in: Expert opinion on investigational drugs | 2008

von Ashwell, S. | Janetka, J. | Zabludoff, S.

10

Discovery of a novel class of 2-ureido thiophene carboxamide checkpoint kinase inhibitors

enthalten in: Bioorganic & medicinal chemistry letters | 2008

von Janetka, J. | Almeida, L. | Ashwell, S. | +18

1
[1]